IMMX
IMMX
NASDAQ · Biotechnology

Immix Biopharma Inc

$8.72
-0.41 (-4.49%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +37.4% upside
Low Target $7.05
Average Target $11.98
High Target $14.20
Current Price $8.72
Current
$8.72
Target
$11.98
$7.05 $11.98 avg $14.20
Scenario Analysis
Bear Case
$7.05
-19.2%
Low target
Base Case
$11.98
+37.4%
Avg target
Bull Case
$14.20
+62.8%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$11.61
-24.9% from high
52-Week Low
$1.94
+349.5% from low
Target vs 52W High
$11.98
+3.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%